Progression of Alzheimer's disease as measured by Clinical Dementia Rating Sum of Boxes scores

Alzheimer's and Dementia

Volumn 9, Issue 1 SUPPL., 2013, Pages

  Williams, Monique M ^a   Storandt, Martha ^a,b   Roe, Catherine M ^a   Morris, John C ^a,b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY   (United States)

Author keywords

Alzheimer's disease; Assessment of dementia; Clinical Dementia Rating; Clinical Dementia Rating Sum of Boxes; Cohort studies

Indexed keywords

APOLIPOPROTEIN E4;

AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ASSESSMENT; CLINICAL DEMENTIA RATING; CLINICAL DEMENTIA RATING SUM OF BOXES; DISEASE COURSE; FEMALE; GENOTYPE; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; NEUROPSYCHOLOGICAL TESTS;

EID: 84873408238     PISSN: 15525260     EISSN: 15525279     Source Type: Journal    
DOI: 10.1016/j.jalz.2012.01.005     Document Type: Article

References (41)

1. P. Leber Guidelines for the clinical evaluation of antidementia drugs 1990 US Food and Drug Administration Rockville, MD
2. R.B. Mani The evaluation of disease modifying therapies in Alzheimer's disease: a regulatory viewpoint Stat Med 23 2004 305 314
3. C.P. Hughes, L. Berg, W.L. Danziger, L.A. Coben, and R.L. Martin A new clinical scale for the staging of dementia Br J Psychiatry 140 1982 566 572
4. J.C. Morris The Clinical Dementia Rating (CDR): current version and scoring rules Neurology 43 1993 2412 2414
5. J.C. Morris Clinical dementia rating: a reliable and valid diagnostic and staging measure for dementia of the Alzheimer type Int Psychogeriatr 9 Suppl 1 1997 173 176 discussion 177-8
6. N. Coley, S. Andrieu, M. Jaros, M. Weiner, J. Cedarbaum, and B. Vellas Suitability of the Clinical Dementia Rating-Sum of Boxes as a single primary endpoint for Alzheimer's disease trials Alzheimers Dement 7 2011 602 610
7. G. McKhann, D. Drachman, M. Folstein, R. Katzman, D. Price, and E.M. Stadlan Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease Neurology 34 1984 939 944
8. J.C. Morris, D.W. McKeel Jr., K. Fulling, R.M. Torack, and L. Berg Validation of clinical diagnostic criteria for Alzheimer's disease Ann Neurol 24 1988 17 22
9. W.J. Burke, J.P. Miller, E.H. Rubin, J.C. Morris, L.A. Coben, and J. Duchek Reliability of the Washington University Clinical Dementia Rating Arch Neurol 45 1988 31 32
10. M.M. McCulla, M. Coats, N. Van Fleet, J. Duchek, E. Grant, and J.C. Morris Reliability of clinical nurse specialists in the staging of dementia Arch Neurol 46 1989 1210 1211
11. J.C. Morris, C. Ernesto, K. Schafer, M. Coats, S. Leon, and M. Sano Clinical dementia rating training and reliability in multicenter studies: the Alzheimer's Disease Cooperative Study experience Neurology 48 1997 1508 1510
12. K. Rockwood, D. Strang, C. MacKnight, R. Downer, and J.C. Morris Interrater reliability of the Clinical Dementia Rating in a multicenter trial J Am Geriatr Soc 48 2000 558 559
13. K.A. Schafer, R.E. Tractenberg, M. Sano, J.A. Mackell, R.G. Thomas, and A. Gamst Reliability monitoring of the clinical dementia rating in multicenter clinical trials Alzheimer Dis Assoc Disord 18 2004 219 222
14. L. Berg, D.W. McKeel Jr., J.P. Miller, M. Storandt, E.H. Rubin, and J.C. Morris Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype Arch Neurol 55 1998 326 335
15. M. Storandt, E.A. Grant, J.P. Miller, and J.C. Morris Longitudinal course and neuropathologic outcomes in original vs revised MCI and in pre-MCI Neurology 67 2006 467 473
16. L. Berg, J.P. Miller, J. Baty, E.H. Rubin, J.C. Morris, and G. Figiel Mild senile dementia of the Alzheimer type: part 4. Evaluation of intervention Ann Neurol 31 1992 242 249
17. C.A. Lynch, C. Walsh, A. Blanco, M. Moran, R.F. Coen, and J.B. Walsh The clinical dementia rating sum of box score in mild dementia Dement Geriatr Cogn Disord 21 2006 40 43
18. M.R. Farlow, S. Salloway, P.N. Tariot, J. Yardley, M.L. Moline, and Q. Wang Effectiveness and tolerability of high-dose (23 mg/d) versus standard-dose (10 mg/d) donepezil in moderate to severe Alzheimer's disease: a 24-week, randomized, double-blind study Clin Ther 32 2010 1234 1251
19. M. Grundman, R.C. Petersen, S.H. Ferris, R.G. Thomas, P.S. Aisen, and D.A. Bennett Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials Arch Neurol 61 2004 59 66
20. J.F. Quinn, R. Raman, R.G. Thomas, K. Yurko-Mauro, E.B. Nelson, and C. Van Dyck Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial JAMA 304 2010 1903 1911
21. L.S. Schneider, and M. Sano Current Alzheimer's disease clinical trials: methods and placebo outcomes Alzheimers Dement 5 2009 388 397
22. B.J. Snider, A.M. Fagan, C. Roe, A.R. Shah, E.A. Grant, and C. Xiong Cerebrospinal fluid biomarkers and rate of cognitive decline in very mild dementia of the Alzheimer type Arch Neurol 66 2009 638 645
23. S.E. O'Bryant, S.C. Waring, C.M. Cullum, J. Hall, L. Lacritz, and P.J. Massman Staging dementia using Clinical Dementia Rating Scale Sum of Boxes scores: a Texas Alzheimer's research consortium study Arch Neurol 65 2008 1091 1095
24. H.C. Rossetti, C. Munro Cullum, L.S. Hynan, and L.H. Lacritz The CERAD Neuropsychologic Battery Total Score and the progression of Alzheimer disease Alzheimer Dis Assoc Disord 24 2010 138 142
25. J.T. Tschanz, C.D. Corcoran, S. Schwartz, K. Triber, R.C. Green, and M.C. Norton Progression of cognitive, functional, and neuropsychiatric symptom domains in a population cohort with Alzheimer dementia: the Cache County dementia progression study Am J Geriatr Psychiatry 19 2011 532 542
26. P.S. Aisen, R.C. Petersen, M.C. Donohue, A. Gamst, R. Raman, and R.G. Thomas Clinical Core of the Alzheimer's Disease Neuroimaging Initiative: progress and plans Alzheimers Dement 6 2010 239 246
27. M.M. Williams, C.M. Roe, and J.C. Morris Stability of the Clinical Dementia Rating, 1979-2007 Arch Neurol 66 2009 773 777
28. M.S. Albert, S.T. Dekosky, D. Dickson, B. Dubois, H.H. Feldman, and N.C. Fox The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease Alzheimers Dement 7 2011 270 279
29. G.M. McKhann, D.S. Knopman, H. Chertkow, B.T. Hyman, C.R. Jack Jr., and C.H. Kawas The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease Alzheimers Dement 7 2011 263 269
30. R.A. Sperling, P.S. Aisen, L.A. Beckett, D.A. Bennett, S. Craft, and A.M. Fagan Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease Alzheimers Dement 7 2011 280 292
31. R. Katzman, T. Brown, P. Fuld, A. Peck, R. Schechter, and H. Schimmel Validation of a short Orientation-Memory-Concentration Test of cognitive impairment Am J Psychiatry 140 1983 734 739
32. M.F. Folstein, S.E. Folstein, and P.R. McHugh "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician J Psychiatr Res 12 1975 189 198
33. D.M. Dreyfus, C.M. Roe, and J.C. Morris Autobiographical memory task in assessing dementia Arch Neurol 67 2010 862 866
34. C. Talbot, C. Lendon, N. Craddock, S. Shears, J.C. Morris, and A. Goate Protection against Alzheimer's disease with apoE epsilon 2 Lancet 343 1994 1432 1433
35. D.K. Johnson, M. Storandt, J.C. Morris, and J.E. Galvin Longitudinal study of the transition from healthy aging to Alzheimer's disease Arch Neurol 66 2009 1254 1259
36. M. Storandt, E.A. Grant, J.P. Miller, and J.C. Morris Rates of progression in mild cognitive impairment and early Alzheimer's disease Neurology 59 2002 1034 1041
37. J.C. Morris, M. Storandt, J.P. Miller, D.W. McKeel, J.L. Price, and E.H. Rubin Mild cognitive impairment represents early-stage Alzheimer disease Arch Neurol 58 2001 397 405
38. C.A. Martins, A. Oulhaj, C.A. de Jager, and J.H. Williams APOE alleles predict the rate of cognitive decline in Alzheimer disease: a nonlinear model Neurology 65 2005 1888 1893
39. S. Cosentino, N. Scarmeas, E. Helzner, M.M. Glymour, J. Brandt, and M. Albert APOE epsilon 4 allele predicts faster cognitive decline in mild Alzheimer disease Neurology 10 19 Pt 2 2008 1842 1849
40. J.R. Hodges, R. Davies, J. Xuereb, J. Kril, and G. Halliday Survival in frontotemporal dementia Neurology 61 2003 349 354
41. M.M. Williams, C. Xiong, J.C. Morris, and J.E. Galvin Survival and mortality differences between dementia with Lewy bodies vs Alzheimer disease Neurology 67 2006 1935 1941